Gabrielle Donné-Op den Kelder
Translator — Dutch
The Netherlands
Articles translated into Dutch by Gabrielle Donné-Op den Kelder
- Moving into the Fast Lane: uniQure and the FDA Are on the Same Track for Accelerated Approval
- Face-to-face: Huntington’s disease families are heard by the FDA
- Bringing HD Treatments to Market: The Role of Regulatory Oversight
- The dust has settled: Sage’s dalzanemdor won’t advance for cognitive impairment
- We are not alone, and are seeing more RED
- 14 changes for a healthier brain
- 2024 HDBuzz Prize: Social Skills - The Hidden Gem in Improving Quality of Life for People with Huntington's disease?
- Hope vs. hype: seeking truth in recent Prilenia headlines
- SURVEYOR opens the door for drugs that treat cognition
- Blue skies for Skyhawk: Positive news from Phase 1 trial for SKY-0515
- Buckle in: Gene therapy AMT-130 appears to slow down signs of Huntington’s disease in Phase I/II clinical trial
- Positive news from Wave Life Sciences SELECT-HD trial
- No pivot needed for PTC-518
- How many is too many? Exploring the toxic CAG threshold in the Huntington’s disease brain
- Cry your eyes out: detecting huntingtin in tears
- CRISPR-based drugs: one giant leap for mankind
- Steady progress from uniQure - promising data to end the year
- Regulating repetition: Gaining control of CAG repeats could slow progression of Huntington’s disease
- Putting it in print: GENERATION HD1 study results published
- Beyond huntingtin lowering: out-of-the-box approaches for the treatment of HD
- Drug to treat movement symptoms of HD approved by FDA
- Updates from PTC Therapeutics and uniQure on their huntingtin-lowering trials
- PROOF-HD study of pridopidine ends with negative result